Its different with the pill because semaglutide is a protein and your stomach is designed to break proteins down
They may ask questions about: Medical history Other medicines Diet and activity When the discomfort started Tests like an electrocardiogram (ECG), chest X-ray, or blood work may be ordered to rule out heart problems or other conditions
The plus side often goes beyond appearances
Key Metrics & Financial Highlights Metric Value Year 1 Revenue $600-800K Year 3 Revenue $10-18M LTV:CAC Ratio 9.8:1 Gross Margin 66% Target Exit Valuation $60-100M (Years 3-4) Initial Capital Required $50-75K MARKET OPPORTUNITY Market Size & Growth Current market: 12 million Americans on GLP-1 medications 2026 projection: 15+ million users Growth rate: 25% annually Patient spend: $900-1,500/month per patient on medication alone Search intent: 50,000+ monthly searches for GLP-1 nutrition solutions Total Addressable Market 12M users 30% willing to pay = 3.6M addressable customers 3.6M $65/month 12 months = $2.8B annual TAM Conservative penetration of 5-10% = $140-280M realistic market Year 1 serviceable market: 1-2% = $28-56M The Problem GLP-1 patients face three critical, interconnected problems: 1
The leading widespread human exposure to toxins harms reproductive health in both males and females (particularly affecting ovarian function and contributing to PCOS-like symptoms) [14]
If severe gastrointestinal symptoms persist for more than two weeks, earlier thyroid function testing may be warranted
